Literature DB >> 17937842

Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses.

C Azzari1, C Massai, C Poggiolesi, G Indolfi, G Spagnolo, M De Luca, P Gervaso, M de Martino, M Resti.   

Abstract

OBJECTIVE: The aims of the study were to evaluate the economic burden of hospitalisations due to varicella in an Italian paediatric hospital during a 1-year period and to compare the data with potential expenses projected for a varicella mass vaccination programme. RESEARCH DESIGN AND METHODS: An observational, retrospective, cohort study was designed to measure hospital admission costs in a cohort of paediatric patients with varicella in a 12-month period. A cost comparison with a vaccination programme planned to prevent varicella in a whole birth cohort was performed. All children 0-16 years referred to the Anna Meyer Children's Hospital (AMCH) were considered. Since AMCH is a tertiary-level hospital and accept patients from other Italian regions, in order to avoid overestimation of hospitalisation expenses, all analyses pertaining to both vaccination and hospitalisation costs were uniquely calculated on the basis of the cohort of residents in the district of Florence.
RESULTS: A total of 279 children were examined in the emergency department for varicella; 47/279 (16.8%) were sent to the inpatient clinic. The highest rate of hospitalisation (85.1%) was found in children < 4 years of age, and the largest number of complications (87.2%) occurred in previously healthy children. Mean length of hospitalisation (5.7 +/- 0.6 days) was similar to that reported in other western countries.
CONCLUSION: Excluding any indirect cost, permanent sequelae and serious outcomes such as death, hospital expenses (corresponding to euro239 654 in a 1-year period), would account for around 80% of total expenses for vaccinating an entire birth cohort (euro310353).

Entities:  

Mesh:

Year:  2007        PMID: 17937842     DOI: 10.1185/030079907X242610

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  11 in total

1.  Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades.

Authors:  A Bechini; M Chellini; E Pellegrino; E Tiscione; C Lorini; G Bonaccorsi; P Bonanni; S Boccalini
Journal:  J Prev Med Hyg       Date:  2018-06-01

2.  Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.

Authors:  Diego Fridman; Andrea Monti; Marie-Claude Bonnet; Judith Armoni; Daniel Stamboulian
Journal:  Hum Vaccin       Date:  2011-10-01

3.  The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study).

Authors:  Ener Cagri Dinleyici; Zafer Kurugol; Ozden Turel; Nevin Hatipoglu; Ilker Devrim; Hasan Agin; Ilker Gunay; Olcay Yasa; Muferet Erguven; Nuri Bayram; Ali Kizildemir; Emre Alhan; Emine Kocabas; Hasan Tezer; H Hakan Aykan; Nazan Dalgic; Betul Kilic; Gulnar Sensoy; Nursen Belet; Nihan Uygur Kulcu; Aysu Say; Mehmet Ali Tas; Ergin Ciftci; Erdal Ince; Halil Ozdemir; Melike Emiroglu; Dursun Odabas; Zeynel Abidin Yargic; Cagatay Nuhoglu; Kursat Bora Carman; Solmaz Celebi; Mustafa Hacimustafaoglu; Murat Elevli; Zahide Ekici; Umit Celik; Meda Kondolot; Mustafa Ozturk; Anil Tapisiz; Metehan Ozen; Harun Tepeli; Aslinur Parlakay; Ates Kara; Ayper Somer; Bahar Caliskan; Sevtap Velipasalioglu; Selim Oncel; Emin Sami Arisoy; Ekrem Guler; Tahir Dalkiran; Denizmen Aygun; Saadet Akarsu
Journal:  Eur J Pediatr       Date:  2011-12-16       Impact factor: 3.183

4.  Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study.

Authors:  Filippo Festini; Priscilla Cocchi; Daniela Mambretti; Bruna Tagliabue; Milena Carotti; Daniele Ciofi; Klaus P Biermann; Roberto Schiatti; Franco M Ruggeri; Fernando Maria De Benedictis; Alessandro Plebani; Alfredo Guarino; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2010-08-09       Impact factor: 3.090

5.  Budget impact analysis of universal rotavirus vaccination in the Local Health Unit 11 Empoli, Tuscany, Italy.

Authors:  S Guarducci; C Lorini; M Balli; M Donzellini; P Filidei; E Mugnaini; A Silva; G Mazzoni; G Bonaccorsi; P Bonanni; S Boccalini
Journal:  J Prev Med Hyg       Date:  2015-08-05

6.  The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies.

Authors:  C Azzari; V Baldo; S Giuffrida; R Gani; E O'Brien; C Alimenti; V J Daniels; L J Wolfson
Journal:  Clinicoecon Outcomes Res       Date:  2020-06-08

7.  Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in Italy.

Authors:  Maria Francesca Piazza; Daniela Amicizia; Chiara Paganino; Francesca Marchini; Matteo Astengo; Federico Grammatico; Cecilia Trucchi; Paolo Romairone; Simona Simonetti; Camilla Sticchi; Filippo Ansaldi
Journal:  Vaccines (Basel)       Date:  2021-12-15

8.  Impact of universal vaccination against varicella in Italy.

Authors:  Angela Bechini; Sara Boccalini; Vincenzo Baldo; Silvia Cocchio; Paolo Castiglia; Tolinda Gallo; Sandro Giuffrida; Francesco Locuratolo; Silvio Tafuri; Domenico Martinelli; Rosa Prato; Emanuele Amodio; Francesco Vitale; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

9.  The Bayesian model on human papillomavirus vaccination in Italy lacks transparency.

Authors:  Livio Garattini; Katelijne van de Vooren
Journal:  Med Care       Date:  2013-04       Impact factor: 2.983

10.  The burden of bacteremia and invasive diseases in children aged less than five years with fever in Italy.

Authors:  Chiara Azzari; Maria Moriondo; Pasquale Di Pietro; Cesare Di Bari; Massimo Resti; Francesco Mannelli; Susanna Esposito; Guido Castelli-Gattinara; Antonio Campa; Fernando Maria de Benedictis; Gianni Bona; Lisa Comarella; Katsiaryna Holl; Federico Marchetti
Journal:  Ital J Pediatr       Date:  2015-11-20       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.